Blackstone Inc Compass Therapeutics, Inc. Transaction History
Blackstone Inc
- $22 Billion
- Q1 2025
A detailed history of Blackstone Inc transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Blackstone Inc holds 10,025,151 shares of CMPX stock, worth $25.2 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,025,151
Previous 10,025,151
-0.0%
Holding current value
$25.2 Million
Previous $14.5 Million
31.03%
% of portfolio
0.09%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding CMPX
# of Institutions
127Shares Held
101MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$56.1 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$27.7 Million1.36% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$21.2 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$16.6 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.96MShares$12.5 Million0.56% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $254M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...